HC-006
- Generic Name
- HC-006
Study of HC006 in Combination With a PD-1 Inhibitor in Patients With Advanced Solid Tumors
Phase 1
Not yet recruiting
- Conditions
- Advanced Cancer
- Interventions
- First Posted Date
- 2025-05-09
- Last Posted Date
- 2025-05-09
- Lead Sponsor
- HC Biopharma Inc.
- Target Recruit Count
- 252
- Registration Number
- NCT06963814
A Study of HC006 in Subjects With Advanced Solid Tumors
- First Posted Date
- 2024-03-12
- Last Posted Date
- 2025-05-06
- Lead Sponsor
- HC Biopharma Inc.
- Target Recruit Count
- 76
- Registration Number
- NCT06304571
- Locations
- 🇨🇳
Shanghai East Hospital, Shanghai, Shanghai, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath